Abstract
Hairy cell leukemia (HCL) is a distinct clinicopathologic entity diagnosed via the integration of morphology, clinical findings, and the presence of a characteristic immunophenotype (monoclonal B-cell population expressing bright CD19, CD20, and CD11c/CD22, CD25, and CD103 and lacking CD5 and CD10). Variant HCL immunophenotypes are …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
